No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bortezomib / therapeutic use
-
Dexamethasone / therapeutic use
-
Humans
-
Induction Chemotherapy
-
Lenalidomide / therapeutic use
-
Multiple Myeloma / diagnosis*
-
Multiple Myeloma / therapy*
-
Prognosis
-
Progression-Free Survival
-
Stem Cell Transplantation*
-
Transplantation, Autologous
-
Treatment Outcome
Substances
-
Bortezomib
-
Dexamethasone
-
Lenalidomide